Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma
Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma
复制标题
桥粒芯糖蛋白 3 在食管鳞状细胞癌中表达和定位的改变
DOI:
10.1016/j.acthis.2014.01.010
复制
发表时间:
2014-01-01
影响因子:
2.5
通讯作者:
Li, En-Min
中科院分区:
文献类型:
--
作者:
Fang, Wang-Kai;Chen, Bo;Li, En-Min
Desmoglein 3 (DSG3), a transmembrane cadherin of the desmosomal cell-cell adhesion structure, plays vital roles in the maintenance of normal epithelial tissue architecture. Reports implicating a role for DSG3 expression in cancer are few and contradictory. In this study, immunohistochemical staining was employed to investigate DSG3 expression and subcellular localization in esophageal squamous cell carcinoma (ESCC), and to correlate changes with clinical characteristics. Results indicate that in normal squamous cell epithelia, strong DSG3 immunoreactivity was observed in the Stratum spinosum, and localization occurred only at the cell membrane. In ESCC, DSG3 immunoreactivity displayed an abnormal cytoplasmic localization that was correlated with cell differentiation (P = 0.018). Most strikingly, in 74.1% of the tumors, DSG3 expression was up-regulated and correlated with regional lymph node metastasis (P = 0.036). Moreover, in patients without lymph node metastasis, cytoplasmic localization of DSG3 correlated with poor prognosis (P = 0.044). These results suggest that DSG3 is involved in the development of ESCC and imply that DSG3 overexpression is likely to be an essential contributor to the aggressive features of esophageal cancer. (C) 2014 Elsevier GmbH. All rights reserved.